glp 1 inventor We are honoured to welcome Dr. Lotte Bjerre Knudsen as our speaker for #ARDD2025! Lotte is a co-inventor of the long-acting GLP-1, liraglutide, and has led all biology research programs from diabetes History of GLP-1 Drugs: Complete

The interest in GLP-1s is growing across the globe, he said, which translates to 14 million patients

The important qualifier: the scientific literature on these amino acids and blood pressure does not primarily involve doses at the 30-60mg level, and buyers who are evaluating whether to spend $69 to $294 on a supplement in this category deserve to understand that distinction clearly before making a financial commitment

Low nanomolar concentrations of Cucurbitacin-I induces G2/M phase arrest and apoptosis by perturbing redox homeostasis in gastric cancer cells in vitro and in vivo

Weight loss continued at the 36-week mark and never plateaued, which indicates that a longer trial would still see results